- Home
- ARMP vs PODC Comparison
ARMP vs PODC Comparison
Compare ARMP & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- PODC
- Stock Information
- Founded
- ARMP N/A
- PODC 2013
- Country
- ARMP United States
- PODC United States
- Employees
- ARMP N/A
- PODC N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- PODC
- Sector
- ARMP Health Care
- PODC
- Exchange
- ARMP Nasdaq
- PODC Nasdaq
- Market Cap
- ARMP 52.1M
- PODC 44.3M
- IPO Year
- ARMP N/A
- PODC N/A
- Fundamental
- Price
- ARMP $2.54
- PODC $1.56
- Analyst Decision
- ARMP Strong Buy
- PODC
- Analyst Count
- ARMP 1
- PODC 0
- Target Price
- ARMP $9.00
- PODC N/A
- AVG Volume (30 Days)
- ARMP 13.2K
- PODC 82.5K
- Earning Date
- ARMP 08-12-2025
- PODC 08-12-2025
- Dividend Yield
- ARMP N/A
- PODC N/A
- EPS Growth
- ARMP N/A
- PODC N/A
- EPS
- ARMP N/A
- PODC N/A
- Revenue
- ARMP $4,699,000.00
- PODC $52,119,000.00
- Revenue This Year
- ARMP $8.43
- PODC $17.91
- Revenue Next Year
- ARMP N/A
- PODC $14.41
- P/E Ratio
- ARMP N/A
- PODC N/A
- Revenue Growth
- ARMP 14.24
- PODC 20.36
- 52 Week Low
- ARMP $0.90
- PODC $1.10
- 52 Week High
- ARMP $2.96
- PODC $2.94
- Technical
- Relative Strength Index (RSI)
- ARMP 65.04
- PODC 34.08
- Support Level
- ARMP $2.14
- PODC $1.61
- Resistance Level
- ARMP $2.61
- PODC $1.87
- Average True Range (ATR)
- ARMP 0.14
- PODC 0.18
- MACD
- ARMP -0.00
- PODC -0.05
- Stochastic Oscillator
- ARMP 81.08
- PODC 1.56
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.